Increased Dose of External Beam Radiation Therapy (EBRT) Improves Overall Survival in Men with Prostate Cancer

Dr. Anusha Kalbasi, MD, a resident in the Department of Radiation Oncology, Hospital of the University of Pennsylvania, and colleagues have reported that increased doses of external-beam radiation therapy (EBRT) improve overall survival in men with high and intermediate risk prostate cancer. However, Dr. Anusha Kalbasi and team found that increased dose of external-beam radiation therapy (EBRT) in men with low-risk prostate cancer were not associated with a difference in overall survival. This study was recently published in JAMA Oncology.

Dr. Anusha Kalbasi and colleagues conducted their study by comparing the effectiveness of normal dose versus increased dose EBRT for men diagnosed with prostate cancer from 2004 to 2006, utilizing the National Cancer Database. Three groups of men with prostate cancer were evaluated. The first group was men with high-risk prostate cancer, second with intermediate-risk prostate cancer, and third with low-risk prostate cancer. Comparison of overall survival was done between treatment groups, and in a sub-analysis, dose response for survival was analyzed. Their study result showed that patients with intermediate risk disease were associated with a 7.8% reduction in mortality for every 2-Gy dose of EBRT increased. Men with high-risk prostate cancer also experience a similar reduction of 6.3% in mortality for every 2-Gy dose of EBRT increased. Further details on the study result can be found here.

Dr. Anusha Kalbasi commented that their study suggests that physicians should factor in prostate cancer risk when weighing the benefits and risks of dose-escalated EBRT. Dr. Anthony L. Zietman, MD, and Dr. Phillip J. Gray, MD, both from Massachusetts General Hospital in Boston, uninvolved in this study, mentioned that past randomized clinical trials and studies with more than 10 years of follow-up have not shown any improvement in overall survival with increased dose of EBRT. Therefore, the improvement of overall survival seen in this study seems to suggest a true association between survival and dose that was missing in past randomized clinical trials.

Image Source

Reference Source


About CancerWarrior

Courage, above all things, is the first quality of a warrior. To war with Cancer.


Top Posts | Research

Mediterranean diet

Mediterranean Dietary Lifestyle May Prevent Breast Cancer

Dr. Miguel Á. Martínez-González, MD, from the Instituto de Salud Carlos III in Madrid, and colleagues reported that breast cancer may be prevented by adopting a Mediterranean diet lifestyle that is known to be protective against cardiovascular diseases. The Mediterranean diet c ... ...

Immunological Cancer Therapy Takes Precedence

The human body is very tough. It can take a lot of abuse and still manage to function. However, just like a well-built machine, it is the internals of the human body that matter more than what is outside. So if something attacks from within, there is a chance that it may be enough to take over the ...

Sitting Linked to Increased Risk for Cancer in Women

According to a study conducted by the American Cancer Society, sitting too much can raise cancer risk in females. The study shows that women who spend 6 hours or more of their time sitting have increased cancer risk by 10% in comparison to the women who spend 3 hours of their time per day sitting.T ...

Light to Moderate Alcohol Intake Increases Cancer Risk

Dr. Edward L. Giovannucci, MD, ScD, Professor of Nutrition, Harvard T. H. Chan School of Public Health, Boston, and colleagues reported that light to moderate alcohol intake increases cancer risk. The research team urged for updated health precautions on alcohol intake. The research team explained ...

Coffee Might Lower the Recurrence Risk of Colon Cancer

Dr. Charles Fuchs, MD, MPH, from the University of Dana-Farber Cancer Institute in Boston and colleagues reported that coffee might lower the recurrence risk of colon cancer. Despite their findings, the research team warned that these findings are not evidence of causation and are only associations ...